Cancer vaccines based on the identification of genes encoding cancer regression antigens (Q41459252)

1 October 2017

1 reference

title

Cancer vaccines based on the identification of genes encoding cancer regression antigens (English)

1 reference

1 October 2017

Rosenberg SA

1

1 reference

1 October 2017

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

18

1 reference

1 October 2017

175-182

1 reference

1 October 2017

4

1 reference

Genes coding for tumor antigens recognized by cytolytic T lymphocytes

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Characterization of Lymphocytes Infiltrating Human Breast Cancer, Specific Immune Reactivity Detected by Measuring Cytokine Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clon

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984664-6

7 January 2021

10.1016/S0167-5699(97)84664-6

Identifiers

DOI

1 reference

release_4ktyexurvjcnrplzu5sk5gex24

1 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ktyexurvjcnrplzu5sk5gex24

24 November 2022

mapped directly with Wikidata item

PubMed ID

9136454

1 reference

PubMed ID

9136454